News

In Alzheimer’s Disease, Brain Cell Death is Linked to Damage in Skeleton Protecting Those Cells, Study Finds

Researchers have discovered that the skeleton surrounding the nucleus of brain cells is dysfunctional in Alzheimer’s disease patients, which could lead to neuronal death. The study, “Lamin Dysfunction Mediates Neurodegeneration in Tauopathies,” was published in Current Biology. The lamin nucleoskeleton that surrounds the nucleus of cells is important in the…

Allianz Donates $50,000 to Alzheimer’s Association, Helps to Raise Disease Awareness

As part of Allianz Championship week in Boca Raton, Florida, Allianz encouraged golf enthusiasts to share their favorite golf memories on Facebook, Twitter, Instagram and other social media sites — using the hashtag #AllianzBirdies — to raise awareness of the Alzheimer’s Association and its work. Two company groups —  Allianz Life and Allianz Global…

Alzheimer’s Disease Scrutinized With New Technology, May Lead to New Treatments

Researchers at Harvard Medical School and the Koch Institute for Integrative Cancer Research at Massachusetts Institute of Technology have developed a system that allows them to study individual human neurons and other nervous system cells. Researchers have identified the subpopulations of cells responsible for the secretion of Alzheimer’s disease-relevant factors…

Alzheimer’s Disease Biomarker Found; May Help Diagnosis Disease

Tel Aviv University and Harvard researchers have found a new biomarker for cognitive aging and Alzheimer’s disease (AD). Diagnosing Alzheimer’s is not an easy task. The process employs measurements of memory impairment, cognitive skills, functional abilities, and behavioral changes, as well as brain imaging and analyses of the cerebrospinal fluid.

Certain Cells in Brain Likely Trigger Alzheimer’s Disease

In a new study titled “Identification of Vulnerable Cell Types in Major Brain Disorders Using Single Cell Transcriptomes and Expression Weighted Cell Type Enrichment,” researchers pinpointed microglia cells in the brain as the specific cell type that likely triggers not only Alzheimer’s disease, but also multiple sclerosis.

Mouse Model of Alzheimer’s Disease Gets UC San Diego License

Tarrytown, New York-based PsychoGenics has announced its Line-41 mouse model of Alzheimer’s disease (AD) has obtained a license from the University of California, San Diego. This experimental model expresses human APP with the London (V717I) and Swedish (K670N/M671L) mutations under the murine-Thy-1 promoter control. PsychoGenics is a leader in providing preclinical…